Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Prevention of Poststroke Depression
NCT01278498Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Jan 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01278498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278498.